Can Micro-Doses of DNP Slow Motor and Muscle Function in Amyotrophic Lateral Sclerosis Mice?

- Posted by

In this blog, I avoid studies that are not done on humans, firstly because the further away from humans and primates, the less sincere the scientific studies are. Then it is well known that the pre-clinical studies published are all extremely positive in order to attract investors (if possible private) who will finance clinical studies.

2,4-dinitrophenol (DNP)

The study examined here explores whether small doses of 2,4-dinitrophenol, a chemical used in the manufacture of pesticides and slimming drugs because it decreases the metabolic action of mitochondria, could help protect motor neurons, preserve muscle function and slow the progression of amyotrophic lateral sclerosis (ALS) in a mouse model of the disease. The scientists' guiding idea therefore seems to be to slow down the disease, by slowing down the metabolism. This seems absolutely counter-intuitive but the scientists assure that they have had good results. The effective dose of 2,4-dinitrophenol was very low (0.5–1 mg/kg, human equivalent dose 2.5–5 mg/day), making it safer for potential use in humans. enter image description here Dinitrophenol acts as a proton transporter in the mitochondrial membrane, inhibiting oxidative phosphorylation of ATP and making energy production less efficient. This is because some of the energy that is normally produced from cellular respiration is wasted as heat. This inefficiency is proportional to the dose of dinitrophenol that is absorbed. Thus, as the dose increases, energy production becomes less efficient: metabolism is then activated - more fat is burned - to compensate for the inefficiency and meet energy demands.

The researchers used hSOD1G93A mice, a common model of ALS, to test the effects of 2,4-dinitrophenol on motor skills, muscle strength, and disease progression. However, it is important to remember that most ALS patients do not have this mutation and that its notoriety is simply because it was the first mutation to be associated with ALS and that for more than 10 years (from 1993 to 2006) no other deleterious mutations were discovered in ALS.

Results

Mice treated with microdoses of 2,4-dinitrophenol (0.5–1 mg/kg) showed better motor coordination and better results on tests measuring muscle strength, compared to untreated mice. Early treatment initiation (before symptoms appeared) delayed the onset of motor decline, while late treatment initiation (after symptoms appeared) improved motor skills (which were already impaired by the disease) and slowed disease progression. Treated mice retained their ability to perform tasks such as running at 20 cm/s for longer than untreated diseased mice. In some cases, the mice regained lost motor skills, which is unusual in ALS research.

Although ALS damages the connections between nerves and muscles (neuromuscular junctions), treatment with 2,4-dinitrophenol preserved these connections. Treated mice retained a higher number of motor units (groups of muscle fibers controlled by a single neuron), indicating that motor neuron loss was reduced.

Reduced Cellular Stress

2,4-dinitrophenol reduced oxidative stress, a harmful process linked to the progression of ALS. This was demonstrated by lower levels of damaged proteins in treated muscles. While ​​slowing down an ALS patient’s metabolism seems pretty criminal, reducing cellular stress is a very good idea.

The drug also reduced inflammation and activated pathways (like Akt/mTOR) involved in muscle growth and repair.

How would 2,4-dinitrophenol work?

2,4-dinitrophenol acts on mitochondria, the energy producers of cells, by slightly lowering their membrane potential (∆Ψm). This mild “uncoupling” reduces the production of harmful reactive oxygen species (ROS), which can damage cells. 2,4-dinitrophenol may also help clear damaged mitochondria and promote the formation of healthy mitochondria, further protecting neurons and muscles.

Future Directions

While the mouse results are promising, translating these findings to humans requires more research. The study also highlighted some limitations:



Please, help us continue to provide valuable information: